{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 447808600
| IUPAC_name = 2-amino-3-benzoylbenzeneacetamide
| image = Nepafenac-2D-skeletal.svg

<!--Clinical data-->
| tradename = Nevanac
| Drugs.com = {{drugs.com|monograph|nepafenac}}
| MedlinePlus = a606007
| pregnancy_US = C
| legal_US = Rx-only
| legal_status =  
| routes_of_administration = [[Eye drops|Ophthalmic]]

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  

<!--Identifiers-->
| IUPHAR_ligand = 7564
| CAS_number =  
| ATC_prefix = S01
| ATC_suffix = BC10
| ATC_supplemental =  
| PubChem = 151075
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 75922
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB06802
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 133160
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 0J9L7J6V8C
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D05143
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1021

<!--Chemical data-->
| C=15 | H=14 | N=2 | O=2 
| molecular_weight = 254.28 g/mol
| smiles = O=C(c1cccc(c1N)CC(=O)N)c2ccccc2
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C15H14N2O2/c16-13(18)9-11-7-4-8-12(14(11)17)15(19)10-5-2-1-3-6-10/h1-8H,9,17H2,(H2,16,18)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = QEFAQIPZVLVERP-UHFFFAOYSA-N
}}

'''Nepafenac''' is a [[nonsteroidal anti-inflammatory drug]] (NSAID), usually sold as a  [[Prescription drug|prescription]] [[eye drop]] 0.1% solution. Nepafenac is manufactured by [[Alcon]] and sold under the trade name '''Nevanac'''. It is used to treat pain and inflammation associated with [[cataract]] surgery.<ref name="Drugs.com">Nepafenac {{drugs.com|monograph|nepafenac}}</ref>

The usual dose is one drop, thrice a day, in each affected eye beginning one day prior to cataract surgery, continued on the day of surgery and through the first two weeks of the postoperative period.<ref name="Drugs.com" />

Nepafenac is a [[prodrug]] of [[amfenac]], an inhibitor of [[COX-1]] and [[COX-2]] activity.<ref>Drugbank: [http://www.drugbank.ca/drugs/DB06802 Nepafenac]</ref><ref>{{Cite journal 
| last1 = Lira | first1 = R. P. 
| last2 = Fulco | first2 = E. A. 
| last3 = Chaves | first3 = A. 
| last4 = Da Costa Pinto | first4 = F. 
| last5 = Arieta | first5 = F. R. 
| last6 = Lira | first6 = C. E. 
| doi = 10.4103/0301-4738.98705 
| title = Effect of preoperative use of topical prednisolone acetate, ketorolac tromethamine, nepafenac and placebo, on the maintenance of intraoperative mydriasis during cataract surgery: A randomized trial 
| journal = Indian Journal of Ophthalmology 
| volume = 60 
| issue = 4 
| pages = 277â€“281 
| year = 2012 
| pmid = 22824596 
| pmc =3442462 
}}</ref>
Its [[Adverse drug reaction|side effects]] may include decreased visual acuity, a feeling that something is in the eye, increased eye pressure or a sticky sensation, as well as other effects.<ref name="Drugs.com" />

Brand names of Nepafenac include Ilevro and Nevanac. 
==References==
{{reflist}}

{{NSAIDs}}

[[Category:Nonsteroidal anti-inflammatory drugs]]
[[Category:Acetamides]]
[[Category:Anilines]]
[[Category:Benzophenones]]
[[Category:Prodrugs]]


{{pharma-stub}}